You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

13-134

Showing 1 - 25 of 6,887
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bronchial Asthma Trial in Poland, Ukraine (beclomethasone dipropionate plus formoterol fumarate combination, fluticasone

Completed
  • Bronchial Asthma
  • beclomethasone dipropionate plus formoterol fumarate combination
  • fluticasone propionate plus salmeterol xinafoate combination
  • Gdansk, Poland
  • +11 more
Jul 30, 2020

Hemophilia A Trial in Worldwide (Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, PEGylated Recombinant Factor

Completed
Has Results
  • Hemophilia A
  • Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method
  • PEGylated Recombinant Factor VIII
  • Phoenix, Arizona
  • +38 more
Apr 30, 2021

Non-alcoholic Steatohepatitis Trial in Montreal (NNC0194-0499, Semaglutide, NNC0194-0499/Semaglutide A (40/3.20 mg/mL))

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • Montreal, Quebec, Canada
    Novo Nordisk Investigational Site
Mar 9, 2023

Metastatic Castration Sensitive Prostate Cancer Trial in New York (Degarelix, Ipilimumab, Radical Prostatectomy)

Active, not recruiting
  • Metastatic Castration Sensitive Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 4, 2022

Healthy Trial (Ketamine, Ts-134, Placebo)

Recruiting
  • Healthy
  • New York, New York
    NYSPI
Jan 3, 2023

Hemophilia A Trial in Worldwide (Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, PEGylated Recombinant Factor

Completed
Has Results
  • Hemophilia A
  • Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method
  • PEGylated Recombinant Factor VIII
  • Aurora, Colorado
  • +71 more
Apr 30, 2021

Global, Multicentre, Non Interventional Advagraf Conversion

Completed
  • Kidney Transplantation
  • Camperdown, New South Wales, Australia
  • +128 more
Nov 10, 2022

Papulopustular Rosacea Trial in United States (FMX103 1.5%)

Completed
Has Results
  • Papulopustular Rosacea
  • FMX103 1.5%
  • Glendale, Arizona
  • +78 more
Jan 13, 2022

NSCLC NSCLC Trial in Worldwide (Durvalumab, Placebo for Olaparib, Olaparib)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer NSCLC
  • Bonita Springs, Florida
  • +67 more
Nov 15, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
  • +11 more
Nov 23, 2022

Chart Review of Repatha® in Subjects With Hyperlipidaemia

Completed
  • Hypercholesterolaemia
    • Feldkirch, Austria
    • +183 more
    Jul 15, 2022

    Hepatocellular Carcinoma Trial (biological, drug, other)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • Pembrolizumab
    • +2 more
    • (no location specified)
    Aug 30, 2022

    Anatomical and Perioperative Predisposing Factor for Limb

    Completed
    • Aneurysm Abdominal
      • Milan, Italy
        IRCCS Ospedale San Raffaele
      Nov 10, 2022

      Post-cesarean Pain Trial in Columbus (TrueRelief device, Sham TrueRelief device)

      Recruiting
      • Post-cesarean Pain
      • TrueRelief device
      • Sham TrueRelief device
      • Columbus, Ohio
        The Ohio State University Wexner Medical Center OB/GYN Maternal
      May 31, 2022

      Phenylketonurias Trial in Aurora (RTX-134)

      Active, not recruiting
      • Phenylketonurias
      • Aurora, Colorado
        Children's Hospital Colorado
      Jan 6, 2022

      Peritoneal Dialysis Trial (continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD))

      Not yet recruiting
      • Peritoneal Dialysis
      • continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)
      • (no location specified)
      Jul 3, 2022

      Natural Progression of Dry Age-related Macular Degeneration

      Recruiting
      • Dry Age-related Macular Degeneration
      • +5 more
        • Phoenix, Arizona
        • +65 more
        Feb 22, 2021

        Autism Spectrum Disorder Trial in United States (Folinic Acid, Placebo)

        Recruiting
        • Autism Spectrum Disorder
        • Folinic Acid
        • Placebo
        • Phoenix, Arizona
        • +3 more
        Jan 13, 2022

        Complicated Intra-abdominal Infections Trial in China (Ceftolozane/Tazobactam, Metronidazole, Meropenem)

        Completed
        Has Results
        • Complicated Intra-abdominal Infections
        • Hefei, Anhui, China
        • +24 more
        Jan 13, 2023

        Healthy Volunteers Trial in United States (PF-06881894 by on-body injector, PF-06881894 by prefilled syringe)

        Active, not recruiting
        • Healthy Volunteers
        • PF-06881894 by on-body injector
        • PF-06881894 by prefilled syringe
        • Anaheim, California
        • +3 more
        May 11, 2022

        Sickle Cell Disease Trial in San Antonio, Nedlands (GBT021601)

        Recruiting
        • Sickle Cell Disease
        • San Antonio, Texas
        • +1 more
        Aug 15, 2022

        Perianal Fistula Due to Crohn's Disease (Disorder) Trial in Cleveland (Mesenchymal stem cells)

        Recruiting
        • Perianal Fistula Due to Crohn's Disease (Disorder)
        • Mesenchymal stem cells
        • Cleveland, Ohio
          Cleveland Clinic
        Apr 1, 2022

        Multiple Sclerosis, Relapsing-Remitting Trial in Canada, United States (23-PPV, 13-PCV Booster, Influenza Vaccine)

        Completed
        Has Results
        • Multiple Sclerosis, Relapsing-Remitting
        • 23-PPV
        • +5 more
        • Cullman, Alabama
        • +21 more
        Apr 4, 2022

        Gastric Cancer, Gastric Adenocarcinoma, Peritoneal Carcinomatosis Trial in Montréal, Quebec City (Indocyanine green)

        Recruiting
        • Gastric Cancer
        • +3 more
        • Indocyanine green
        • Montréal, Quebec, Canada
        • +1 more
        Jan 8, 2023

        Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

        Active, not recruiting
        • Renal Cell Carcinoma
        • La Jolla, California
        • +159 more
        Jan 23, 2023